View Cart (0 items)

Pharmaceutical

Pfizer shareholders reject call to oust board members

May 4, 2006
Shareholders of pharmaceutical company Pfizer Inc. rejected a call recently to oust some members of the company''s board for approving a deal to pay its chief executive officer as much
Read More

Swiss biotech company withdraws sale offer

April 10, 2006
Swiss biotechnology company Serono, the focus of takeover speculation for months, said it was no longer up for sale because offers had fallen short of its value, the Associated Press
Read More

Bayer outbids Merck for Schering

March 27, 2006
Bayer AG''s 16.3 billion euro ($19.6 billion) offer for drugmaker Schering AG was embraced by its target last week as German rival Merck abandoned its own takeover offer, the Associated
Read More

Court hearing Vioxx case evacuated in alert

March 23, 2006
A courthouse in Atlantic City where a case is being heard against drug company Merck & Co. over pain-relieving drug Vioxx was evacuated March 22 after a suspicious device
Read More

Casino workers to decide next Vioxx case

March 6, 2006
The Associated Press reports that Atlantic City casino workers will help decide whether drug manufacturer Merck & Co. is to blame for heart attacks suffered by two New Jersey men
Read More

Merck cleared in first federal Vioxx case

February 20, 2006
A federal jury handed Merck & Co. a major victory last Friday, clearing the drug maker of any responsibility in the death of a 53-year-old Florida man who had a
Read More

GlaxoSmithKline buys Croatian drug maker

February 20, 2006
Croatian drug maker Pliva recently sold its research and development center to GlaxoSmithKline PLC in a deal worth up to US$50 million (euro60 million). According to the Associated Press, Pliva
Read More

Potential New Orleans jurors get Vioxx retrial notices

January 23, 2006
Although New Orleans has fewer than half the residents it did before Hurricane Katrina, the judge hearing the first federal Vioxx trial has told attorneys he does not expect any
Read More

Glaxo seeks preliminary bird flu vaccine approval

January 10, 2006
GlaxoSmithKline PLC said it is seeking preliminary approval in Europe to market a vaccine against pandemic influenza, which experts fear may be triggered by bird flu, the Associated Press reports.
Read More

Merck to eliminate 7,000 jobs, 5 plants

November 29, 2005
Faced with thousands of Vioxx lawsuits, the loss of patent protection for a key product and a weak array of drugs in development, Merck & Co. is axing more than
Read More